Debolai Biotechnology Co., Limited – Trademark Portfolio

Entity Type: 03

Debolai Biotechnology Co., Limited holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include AHETE, KGFSD, CHAREO, SLVANO, and VEVOEC. The owner is based in KOWLOON, HONG KONG.

RM4, 16/F, HO KING COMM CTR

2-16 FAYUEN ST, MONGKOK

KOWLOON, HONG KONG 999077 , HK

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AHETE
AHETE
Registered 2023
CHAREO
CHAREO
Registered 2023
KGFSD
KGFSD
Registered 2023
VEVOEC
VEVOEC
Registered 2023
SLVANO
SLVANO
Registered 2023

Trademark Classifications

Debolai Biotechnology Co., Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Debolai Biotechnology Co., Limited have?

Debolai Biotechnology Co., Limited has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Debolai Biotechnology Co., Limited file in?

Debolai Biotechnology Co., Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Debolai Biotechnology Co., Limited's most well-known trademarks?

Debolai Biotechnology Co., Limited's registered trademark portfolio includes well-known marks such as AHETE, KGFSD, CHAREO, SLVANO, and VEVOEC. These are among 5 currently registered trademarks in the portfolio.

What is Debolai Biotechnology Co., Limited's trademark registration success rate?

Debolai Biotechnology Co., Limited has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.